J Robbins, MJ Merino, JD Boice Jr, E Ron, … - Annals of internal …, 1991 - Am Coll Physicians This conference focuses on the controversies about managing thyroid cancer, emphasizing the
possibility that the treatment of patients with potentially fatal thyroid cancer may be improved.
Although the mortality rate from thyroid cancer is low, it is the highest among cancers ... Cited by 148 - Related articles - All 5 versions
BL Solomon, L Wartofsky, KD Burman - Journal of Clinical Endocrinology …, 1996 - Endocrine Soc Page 1. 0021-972x/96/$03.00/0 Journal of Clinical Endocrinology and Metabolism Copyright
0 1996 by The Endocrine Society Vol. 81, No. 1 Printed in USA Current Trends in the
Management of Well Differentiated Papillary Thyroid Carcinoma* ... Cited by 102 - Related articles - All 5 versions
S MARTIN, T MAURICE, FDE VATHAIRE, H … - Journal of Clinical …, 1986 - Endocrine Soc We assessed the results of treatment in 283 patients with lung or bone metastases from differentiated
thyroid carcinoma who were followed for up to 40 yr (median, 44 months) after the discovery
of the metastases. ... * To whom requests for reprints should be addressed. Cited by 312 - Related articles - All 3 versions
TL Johnson, RV Lloyd, NW Thompson, WH … - The American journal …, 1988 - journals.lww.com The American Journal of Surgical Pathology 12(1): 22-27, 1988 1988 Raven Press, Ltd., New
York Prognostic Implications of the Tall Cell Variant of Papillary Thyroid Carcinoma Terri L.
Johnson, MD, Ricardo V. Lloyd, MD, Norman W. Thompson, MD, William H. Beierwaltes, ... Cited by 152 - Related articles - All 4 versions
OH Clark, QY Duh - The Medical clinics of North America, 1991 - ncbi.nlm.nih.gov There have been important recent advances in our understanding of the biologic nature of thyroid
cancer and in the early diagnosis of the disease. Despite these advances, there is still considerable
controversy over the management of thyroid cancer, including the extent of surgery, the ... Cited by 62 - Related articles - All 2 versions
KB Ain - Endocrinology and metabolism clinics of North America, 1995 - ncbi.nlm.nih.gov Most papillary carcinomas do not cause death or significant morbidity. Current modes of therapy
when appropriately applied, appear effective for 80% to 90% of patients. The clinical challenge
is to identify the minority of patients who will suffer greatly from tumors to direct ... Cited by 85 - Related articles - BL Direct - All 2 versions
ID Hay - Endocrinol Metab Clin North Am, 1990 - osti.gov Multiple prognostic factors for outcome in papillary thyroid carcinoma are identified.^For a cohort
of 1500 consecutive patients followed an average of 16 years, survival rates for tumor recurrence
and cause-specific mortality are described.^Risk groups derived from novel prognostic ... Cited by 322 - Related articles - Cached - All 2 versions
B Niederle, R Roka, M Schemper, A Fritsch, M Weissel, … - Surgery, 1986 - cat.inist.fr Surgical treatment of distant metastases in differentiated thyroid cancer: indication
and results. B NIEDERLE, R ROKA, M SCHEMPER, A FRITSCH, M WEISSEL, W
RAMACH Surgery 100:66, 1088-1097, Elsevier, 1986. L'exérèse ... Cited by 75 - Related articles - All 2 versions
K Shimaoka, DA Schoenfeld, WD De Wys, RH … - CA A Cancer Journal … - interscience.wiley.com A randomized evaluation of the effectiveness and toxicity of the combination of doxorubicin and
cisplatin and of doxorubicin alone in patients with advanced thyroid carcinoma was carried
out. Ninety-two patients were entered and 84 were evaluable. They were stratified ... Cited by 182 - Related articles - All 3 versions
LA Akslen - CA A Cancer Journal for Clinicians - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 87 - Related articles - BL Direct - All 3 versions
